Connect Biopharma Holdings Ltd (CNTB) Stock Analysis

Connect Biopharma Holdings Ltd (CNTB) is a publicly traded company in the HEALTHCARE sector. It trades at $2.15, carries a market capitalization of $156.78M. This page summarizes the public market data, fundamentals, and frequently asked questions for CNTB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.15
• Market Cap: $156.78M
• EPS: $-1.15
• 52-Week High: $3.82
• 52-Week Low: $0.73

Market Sentiment

Connect Biopharma Holdings Ltd currently has a Bullish sentiment score of 0.21.

About Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical firm headquartered in Taicang, China, specializing in the discovery and development of innovative immune modulators targeted at severe autoimmune diseases and inflammatory conditions. With a robust pipeline of product candidates, the company is dedicated to addressing significant unmet medical needs, highlighting its potential to deliver breakthrough therapies that improve patient outcomes. By harnessing advanced scienti...

GNG Research Analysis

GNG Research scores Connect Biopharma Holdings Ltd (CNTB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CNTB.

Frequently Asked Questions

Does CNTB pay dividends?

Connect Biopharma Holdings Ltd (CNTB) does not currently pay a regular dividend.

What is CNTB's market cap?

Connect Biopharma Holdings Ltd (CNTB) has a market capitalization of $156.78M with a current stock price of $2.15.